ScoreWhy is Venus Remedies Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
With a growth in Operating Profit of 96.37%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 5 consecutive quarters
- ROCE(HY) Highest at 13.99%
- INVENTORY TURNOVER RATIO(HY) Highest at 6.58 times
- PBDIT(Q) Highest at Rs 37.52 cr.
3
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 12-Mar-26 and has generated 22.73% returns since then
- Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
4
With ROE of 10.5, it has a Fair valuation with a 2.4 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 220.39%, its profits have risen by 182.3% ; the PEG ratio of the company is 0.1
5
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 0.72% over the previous quarter and collectively hold 4% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Venus Remedies should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Venus Remedies for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Venus Remedies
210.84%
4.14
53.21%
Sensex
-1.65%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.65%
EBIT Growth (5y)
56.81%
EBIT to Interest (avg)
54.78
Debt to EBITDA (avg)
0.54
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
1.14
Tax Ratio
23.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.81%
ROCE (avg)
9.53%
ROE (avg)
8.61%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
37
Price to Book Value
3.06
EV to EBIT
13.88
EV to EBITDA
11.68
EV to Capital Employed
3.39
EV to Sales
2.39
PEG Ratio
0.11
Dividend Yield
0.66%
ROCE (Latest)
21.23%
ROE (Latest)
15.49%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend23What is working for the Company
PBT LESS OI(Q)
At Rs 27.42 cr has Grown at 198.37%
PAT(Q)
At Rs 22.97 cr has Grown at 139.3%
ROCE(HY)
Highest at 19.85%
NET SALES(Q)
At Rs 178.86 cr has Grown at 30.38%
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 29.61 cr
Loading Valuation Snapshot...
Here's what is working for Venus Remedies
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 27.42 cr has Grown at 198.37%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 22.97 cr has Grown at 139.3%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 178.86 cr has Grown at 30.38%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Venus Remedies
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 29.61 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
